Showing 5961-5970 of 21466 results for "".
- Global CME Conference to Spotlight Eczema Burden, Treatment Advanceshttps://reachmd.com/news/global-cme-conference-to-spotlight-eczema-burden-treatment-advances/2483912/Health & Wellness Global Alliance will host its inaugural H&W Global Dermatology CME Conference November 12-16, 2025, aiming to spotlight the international burden of eczematous diseases. The event aligns with the mission
- Portable Air Sampler Detects Airborne TB DNA in South African Clinicshttps://reachmd.com/news/portable-air-sampler-detects-airborne-tb-dna-in-south-african-clinics/2483908/A study published in Open Forum Infectious Diseases reports that a small, electrostatic air-sampling device can detect aerosolized
- New Antibody Therapy Targets and Reprograms Resistant Tumors in Preclinical Studyhttps://reachmd.com/news/new-antibody-therapy-targets-and-reprograms-resistant-tumors-in-preclinical-study/2483894/A team of scientists at UCLA, in collaboration with international partners, has developed a promising new strategy to treat some of the most aggressive
- How Sleep Habits Reflect Mental Health, Cognition, and Lifestyle: A New Neural Blueprint Emergeshttps://reachmd.com/news/how-sleep-habits-reflect-mental-health-cognition-and-lifestyle-a-new-neural-blueprint-emerges/2483897/In a study published this week in PLOS Biology, researchers have identified five distinct "sleep-biopsychosocial" profiles that link
- Association Between Diet Quality and Frailty with All-Cause Mortality and Life Expectancy in Older Adultshttps://reachmd.com/news/association-between-diet-quality-and-frailty-with-all-cause-mortality-and-life-expectancy-in-older-adults/2483892/A new study published in Nutrients suggests that maintaining a high-quality diet could significantly blunt the life-shortening impact of frailty in middle-aged and olde
- Experimental Nanobody Shows Promise for Psoriatic Arthritis in Phase 2 Trialhttps://reachmd.com/news/experimental-nanobody-shows-promise-for-psoriatic-arthritis-in-phase-2-trial/2483875/A novel nanobody therapy targeting dual inflammatory pathways has shown encouraging results in treating psoriatic arthritis (PsA), a complex and disabling autoimmune disease. The investigational agent
- Genetic Score in ZMIZ1/TGF‑β/STAT Pathway Forecasts Biologic Drug Persistence in Psoriasishttps://reachmd.com/news/genetic-score-in-zmiz1tgfstat-pathway-forecasts-biologic-drug-persistence-in-psoriasis/2483888/In a newly published study in Advances in Therapy, investigators report that a pathway‑based genetic score may predict how long patients with moderate
- Rare Case of Urachal Neuroendocrine Carcinoma Reveals Potential for Targeted Therapyhttps://reachmd.com/news/rare-case-of-urachal-neuroendocrine-carcinoma-reveals-potential-for-targeted-therapy/2483886/In a newly published case report, Japanese researchers describe one of the few documented instances of neuroendocrine carcinoma (NEC) arising from the urachus, providing detailed pathological
- Measles Resurgence Oct 2025: Linking Alberta’s Surge and U.S. Clusters to Vaccination Gaps and Policy Responseshttps://reachmd.com/news/measles-resurgence-oct-2025-linking-albertas-surge-and-us-clusters-to-vaccination-gaps-and-policy-responses/2483879/The near-1,914-case measles surge in Alberta since March 2025, coupled with emerging U.S. clusters, represents a preventable re-establishment risk for elimination-era regions and demands immediate clinical and public-health attention. Rapid operational adjustments now can blunt cross-border
- Dual-Targeting Nanobody Sonelokimab Shows Promise in Psoriatic Arthritis Phase 2 Trialhttps://reachmd.com/news/dual-targeting-nanobody-sonelokimab-shows-promise-in-psoriatic-arthritis-phase-2-trial/2483881/A novel nanobody therapy targeting dual inflammatory pathways has shown encouraging results in treating psoriatic arthritis (PsA), a complex and disabling autoimmune disease. The investigational agent,